HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Langholz Selected Research

Heparin (Liquaemin)

4/2004Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Langholz Research Topics

Disease

2Crohn Disease (Crohn's Disease)
11/2012 - 02/2004
1Common Variable Immunodeficiency
01/2011
1Hemorrhage
10/2010
1Varicose Veins (Varicose Vein)
10/2010
1Colitis
04/2004
1Ulcerative Colitis
04/2004
1Colorectal Neoplasms (Colorectal Cancer)
02/2004

Drug/Important Bio-Agent (IBA)

1Infliximab (Remicade)FDA Link
11/2012
1Capsules (Microcapsules)IBA
01/2011
1isosorbide-5-mononitrate (Ismo)FDA LinkGeneric
10/2010
1Tinzaparin (Innohep)FDA Link
04/2004
1Heparin (Liquaemin)FDA LinkGeneric
04/2004
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
04/2004
1Mesalamine (Mesalazine)FDA LinkGeneric
02/2004

Therapy/Procedure

2Therapeutics
11/2012 - 10/2010
1Secondary Prevention
10/2010